
---
sidebar_position: 63
---
        <h3>clinical-evaluation-and-clinical-investigations</h3>
<h1>Clinical-investigations-on-incapacitated-subjects</h1>
<h2>Article 64</h2>
   <p class="stitle-article-norm">Clinical investigations on incapacitated subjects</p>
   <p class="norm">1.&nbsp;&nbsp;In the case of incapacitated subjects 
who have not given, or have not refused to give, informed consent before
 the onset of their incapacity, a clinical investigation may be 
conducted only where, in addition to the conditions set out in 
Article&nbsp;62(4), all of the following conditions are met:</p>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(a)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the informed consent of their legally designated representative has been obtained;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(b)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the incapacitated subjects have received the 
information referred to in Article&nbsp;63(2) in a way that is adequate 
in view of their capacity to understand it;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(c)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the explicit wish of an incapacitated subject 
who is capable of forming an opinion and assessing the information 
referred to in Article&nbsp;63(2) to refuse participation in, or to 
withdraw from, the clinical investigation at any time, is respected by 
the investigator;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(d)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">no incentives or financial inducements are 
given to subjects or their legally designated representatives, except 
for compensation for expenses and loss of earnings directly related to 
the participation in the clinical investigation;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(e)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the clinical investigation is essential with 
respect to incapacitated subjects and data of comparable validity cannot
 be obtained in clinical investigations on persons able to give informed
 consent, or by other research methods;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(f)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the clinical investigation relates directly to a medical condition from which the subject suffers;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(g)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">there are scientific grounds for expecting that
 participation in the clinical investigation will produce a direct 
benefit to the incapacitated subject outweighing the risks and burdens 
involved.</p>
      </div>
   </div>
   <p class="norm">2.&nbsp;&nbsp;The subject shall as far as possible take part in the informed consent procedure.</p>